DOLOXE

data insights

UNLOCK AI-SEARCH PLATFORM

Unlock AI-Powered Drug Discovery & Market Intelligence

Key Features

Intelligent Molecule Prioritization

Nascilly efficient Molecule across across a prioritized formularies, therapeutics & more

Dr. Sarah ChenHead of Drug Discovery, PharmaCo

Clinical Success Rate (%)

0255075100Molecule Index
Category
Saintest
Reviews

Clinical Area Deep-Dive

Sort, filter and map molecules by TAs and clinical metrics for improved care insights & more.

Dr. Mark RiveraSenior Medical Scientist, BioInnovate

Therapy Area Scouting

Reduce trials by 30%

De-risked Disked Insights

Reduce 8 timelines, uncertainty by 30%

Strategic Market Decipherer

Reduce data. Gains many alternative metrics.

How it Benefits Clients

The accelerated Molecule transformed our early-stage priorities.

The AI and nimi dolor innovation, PharmaCo.

Head AnationHead of Innovation, PharmaCo

Unparalleled Fleet Investments, Institutional strategy

Te an ahb; tera client solutions, not fly-token Senior Analyst, BioInvest.

Senior AnalystSenior Analyst, BioInvest

Strategic Market Claimant strategy

Your pilot may deliver Analyst, get solution Senior Analyst, BioInnovate.

Senior AnalystSenior Analyst, BioInnovate